Skip to main content
SpringerLink
Log in

Deep Venous Thrombosis

  • Chapter
  • First Online:
Vascular Surgery

Part of the book series: New Techniques in Surgery Series ((NEWTECHN,volume 6))

  • 2460 Accesses

Abstract

Acute DVT is a common disease with potentially life-threatening consequences and long-term life-altering complications. It imposes huge economic burden on the society. The disease is difficult to diagnose because of the lack of sensitivity and specificity of its clinical manifestations. Diagnostic algorithms are needed for safe and effective diagnosis. The treatment is standard anticoagulation therapy which reduces significantly the mortality risk and recurrence of the disease but does a much poorer job when it comes to the long-term morbidity of the disease. Active management of acute DVT, especially proximal iliofemoral DVT, using catheter-directed thrombolysis with or without mechanical thrombectomy modalities is gaining momentum and may prove to be the standard therapy of the future as it adds to the standard therapy the significant reduction of the long-term morbidity specifically postthrombotic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Patterson BO, et al. Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis. Arterioscler Thromb Vasc Biol. 2010;30(4):669–74.

    Article  PubMed  CAS  Google Scholar 

  2. Anderson Jr FA, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151(5):933–8.

    Article  PubMed  Google Scholar 

  3. Nordstrom M, et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232(2):155–60.

    Article  PubMed  CAS  Google Scholar 

  4. Hull RD, Pineo GF, Raskob GE. The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects. Haemostasis. 1998;28 Suppl 3:8–16.

    PubMed  CAS  Google Scholar 

  5. Turpie AG, Chin BS, Lip GY. Venous thromboembolism: pathophysiology, clinical features, and prevention. BMJ. 2002;325(7369):887–90.

    Article  PubMed  Google Scholar 

  6. Prandoni P, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125(1):1–7.

    PubMed  CAS  Google Scholar 

  7. Kakkar VV, et al. Natural history of postoperative deep-vein thrombosis. Lancet. 1969;2(7614):230–2.

    Article  PubMed  CAS  Google Scholar 

  8. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: Population-based case–control study. Arch Intern Med. 2000;160:809.

    Article  PubMed  CAS  Google Scholar 

  9. May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8(5):419–27.

    Article  PubMed  CAS  Google Scholar 

  10. Shebel ND, Marin A. Effort thrombosis (Paget-Schroetter syndrome) in active young adults: current concepts in diagnosis and treatment. J Vasc Nurs. 2006;24(4):116–26.

    Article  PubMed  Google Scholar 

  11. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 2008;28(3):387–91.

    Article  PubMed  CAS  Google Scholar 

  12. Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 2003;1(7):1343–8.

    Article  PubMed  CAS  Google Scholar 

  13. van Ramshorst B, et al. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning. Circulation. 1992;86(2):414–9.

    Article  PubMed  Google Scholar 

  14. Killewich LA, et al. Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement. J Vasc Surg. 1997;26(5):861–8.

    Article  PubMed  CAS  Google Scholar 

  15. Prandoni P, et al. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation. 1993;88(4 Pt 1):1730–5.

    Article  PubMed  CAS  Google Scholar 

  16. Hull RD, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1986;315(18):1109–14.

    Article  PubMed  CAS  Google Scholar 

  17. Hull R, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med. 1979;301(16):855–8.

    Article  PubMed  CAS  Google Scholar 

  18. Hingorani A, et al. Upper extremity versus lower extremity deep venous thrombosis. Am J Surg. 1997;174(2):214–7.

    Article  PubMed  CAS  Google Scholar 

  19. Pengo V, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257–64.

    Article  PubMed  CAS  Google Scholar 

  20. Comerota AJ, Gravett MH. Iliofemoral venous thrombosis. J Vasc Surg. 2007;46(5):1065–76.

    Article  PubMed  Google Scholar 

  21. Rao AS, et al. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: an alternative in patients with contraindications to thrombolysis. J Vasc Surg. 2009;50(5):1092–8.

    Article  PubMed  Google Scholar 

  22. Kahn SR, et al. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009;7(5):879–83.

    Article  PubMed  CAS  Google Scholar 

  23. Prandoni P, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004;141(4):249–56.

    PubMed  Google Scholar 

  24. Kahn SR, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost. 2008;6(7):1105–12.

    Article  PubMed  CAS  Google Scholar 

  25. Bezemer ID, et al. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med. 2009;169(6):610–5.

    Article  PubMed  Google Scholar 

  26. Bettmann MA, et al. Contrast venography of the leg: diagnostic efficacy, tolerance, and complication rates with ionic and nonionic contrast media. Radiology. 1987;165(1):113–6.

    PubMed  CAS  Google Scholar 

  27. Mattos MA, et al. Color-flow duplex scanning for the surveillance and diagnosis of acute deep venous thrombosis. J Vasc Surg. 1992;15(2):366–75; discussion 375–6.

    Article  PubMed  CAS  Google Scholar 

  28. Butty S, et al. Body MR venography. Radiol Clin North Am. 2002;40(4):899–919.

    Article  PubMed  Google Scholar 

  29. Peterson DA, et al. Computed tomographic venography is specific but not sensitive for diagnosis of acute lower-extremity deep venous thrombosis in patients with suspected pulmonary embolus. J Vasc Surg. 2001;34(5):798–804.

    Article  PubMed  CAS  Google Scholar 

  30. Kelly J, Hunt BJ. Role of D-dimers in diagnosis of venous thromboembolism. Lancet. 2002;359(9305):456–8.

    Article  PubMed  CAS  Google Scholar 

  31. van der Graaf F, et al. Exclusion of deep venous thrombosis with D-dimer testing – comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost. 2000;83(2):191–8.

    PubMed  Google Scholar 

  32. Wells PS, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet. 1995;345(8961):1326–30.

    Article  PubMed  CAS  Google Scholar 

  33. Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 1997;350:1795.

    Article  PubMed  CAS  Google Scholar 

  34. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-Dimer in the diagnosis of suspected deep-vein thrombosis. N Eng J Med. 2003;349:1227.

    Article  CAS  Google Scholar 

  35. Schutgens RE, et al. Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation. 2003;107(4):593–7.

    Article  PubMed  CAS  Google Scholar 

  36. Kiernan TJ, et al. Current status of pharmacological thrombolytic therapy and mechanical thrombectomy for the treatment of acute deep venous thrombosis. Cardiovasc Hematol Agents Med Chem. 2009;7(1):12–8.

    Article  PubMed  CAS  Google Scholar 

  37. Buller HR, et al. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 suppl):401S–28.

    Article  PubMed  CAS  Google Scholar 

  38. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg. 1993;36(4):359–64.

    PubMed  CAS  Google Scholar 

  39. Killewich LA, et al. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg. 1989;9(1):89–97.

    PubMed  CAS  Google Scholar 

  40. Augustinos P, Ouriel K. Invasive approaches to treatment of venous thromboembolism. Circulation. 2004;110(9 suppl 1):I27–34.

    Article  PubMed  Google Scholar 

  41. Rhodes JM, et al. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg. 2000;31(6):1193–205.

    PubMed  CAS  Google Scholar 

  42. Cho JS, et al. Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function. J Vasc Surg. 1998;28(5):787–99.

    Article  PubMed  CAS  Google Scholar 

  43. Watson L, Armon M. Thrombolysis for acute deep venous thrombosis. Cochrane Database Syst Rev. 2007; Art No. CD002783.

    Google Scholar 

  44. Vedantham S. Catheter-directed thrombolysis for deep vein thrombosis. Curr Opin Hematol. 2010;17(5):464–8.

    Article  PubMed  Google Scholar 

  45. Enden T, et al. Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis – the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771). Am Heart J. 2007;154(5):808–14.

    Article  PubMed  Google Scholar 

  46. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960;1(7138):1309–12.

    Article  PubMed  CAS  Google Scholar 

  47. Hirsh J, Bates SM. Clinical trials that have influenced the treatment of venous thromboembolism: a historical perspective. Ann Intern Med. 2001;134(5):409–17.

    PubMed  CAS  Google Scholar 

  48. Kearon C, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 suppl):454S–545.

    Article  PubMed  CAS  Google Scholar 

  49. Ansell J, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 suppl):160S–98.

    Article  PubMed  CAS  Google Scholar 

  50. Weitz JI. Low-molecular-weight heparins. N Engl J Med. 1997;337(10):688–98.

    Article  PubMed  CAS  Google Scholar 

  51. Kakkar VV, et al. Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis. Blood. 2002;99(6):1965–70.

    Article  PubMed  CAS  Google Scholar 

  52. Lensing AW, et al. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med. 1995;155(6):601–7.

    Article  PubMed  CAS  Google Scholar 

  53. Siragusa S, et al. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med. 1996;100(3):269–77.

    Article  PubMed  CAS  Google Scholar 

  54. Merli G, et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med. 2001;134(3):191–202.

    PubMed  CAS  Google Scholar 

  55. Breddin HK, et al. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med. 2001;344(9):626–31.

    Article  PubMed  CAS  Google Scholar 

  56. Koopman MM, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med. 1996;334(11):682–7.

    Article  PubMed  CAS  Google Scholar 

  57. Dunn A, et al. Effect of intravenous heparin administration on duration of hospitalization. Mayo Clin Proc. 2004;79(2):159–63.

    Article  PubMed  Google Scholar 

  58. Snow V, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2007;146(3):204–10.

    PubMed  Google Scholar 

  59. Hull R, et al. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med. 1982;306(4):189–94.

    Article  PubMed  CAS  Google Scholar 

  60. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet. 1992;340(8824):873–6.

    Google Scholar 

  61. Schulman S, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995;332(25):1661–5.

    Article  PubMed  CAS  Google Scholar 

  62. Baglin T, et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362(9383):523–6.

    Article  PubMed  Google Scholar 

  63. Daniels LB, et al. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol. 1997;80(2):184–8.

    Article  PubMed  CAS  Google Scholar 

  64. Kiernan TJ, Gersh BJ. Thrombolysis in acute myocardial infarction: current status. Med Clin North Am. 2007;91(4):617–37; x.

    Article  PubMed  CAS  Google Scholar 

  65. Schweizer J, et al. Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study. Vasa. 1998;27(3):167–71.

    PubMed  CAS  Google Scholar 

  66. Grunwald MR, Hofmann LV. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol. 2004;15(4):347–52.

    Article  PubMed  Google Scholar 

  67. Janssen MC, et al. Local and systemic thrombolytic therapy for acute deep venous thrombosis. Neth J Med. 2005;63(3):81–90.

    PubMed  CAS  Google Scholar 

  68. Comerota AJ, Paolini D. Treatment of acute iliofemoral deep venous thrombosis: a strategy of thrombus removal. Eur J Vasc Endovasc Surg. 2007;33(3):351–60; discussion 361–2.

    Article  PubMed  CAS  Google Scholar 

  69. Mewissen MW, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211(1):39–49.

    PubMed  CAS  Google Scholar 

  70. Greenberg RK, et al. Mechanical versus chemical thrombolysis: an in vitro differentiation of thrombolytic mechanisms. J Vasc Interv Radiol. 2000;11(2 Pt 1):199–205.

    Article  PubMed  CAS  Google Scholar 

  71. Sharafuddin MJ, Hicks ME. Current status of percutaneous mechanical thrombectomy. Part II. Devices and mechanisms of action. J Vasc Interv Radiol. 1998;9(1 Pt 1):15–31.

    Article  PubMed  CAS  Google Scholar 

  72. Lee KH, et al. Mechanical thrombectomy of acute iliofemoral deep vein thrombosis with use of an Arrow-Trerotola percutaneous thrombectomy device. J Vasc Interv Radiol. 2006;17(3):487–95.

    Article  PubMed  Google Scholar 

  73. Kwon SH, et al. Percutaneous aspiration thrombectomy for the treatment of acute lower extremity deep vein thrombosis: is thrombolysis needed? Clin Radiol. 2009;64(5):484–90.

    Article  PubMed  CAS  Google Scholar 

  74. Vedantham S, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2004;15(6):565–74.

    Article  PubMed  Google Scholar 

  75. McLafferty RB. Endovascular management of deep venous thrombosis. Perspect Vasc Surg Endovasc Ther. 2008;20(1):87–91.

    Article  PubMed  Google Scholar 

  76. Parikh S, et al. Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience. J Vasc Interv Radiol. 2008;19(4):521–8.

    Article  PubMed  Google Scholar 

  77. Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost. 1997;78(3):1063–8.

    PubMed  CAS  Google Scholar 

  78. Oguzkurt L, Tercan F, Ozkan U. Manual aspiration thrombectomy with stent placement: rapid and effective treatment for phlegmasia cerulea dolens with impending venous gangrene. Cardiovasc Intervent Radiol. 2008;31(1):205–8.

    Article  PubMed  Google Scholar 

  79. Sharafuddin MJ, et al. Endovascular management of venous thrombotic and occlusive diseases of the lower extremities. J Vasc Interv Radiol. 2003;14(4):405–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Vascular Surgery, Department of Cardiovascular Surgery, Weil Cornell Medical College, The Methodist Hospital, 6550 Fannin St., Smith Tower, Suite 1401, Houston, TX, 77030, USA

    Hossam F. El-Sayed M.D., Ph.D., RVT

Authors
  1. Hossam F. El-Sayed M.D., Ph.D., RVT
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hossam F. El-Sayed M.D., Ph.D., RVT .

Editor information

Editors and Affiliations

  1. Medical Center, Department of Surgery, American University of Beirut, Cairo Street, Beirut, Lebanon

    Jamal J. Hoballah

  2. Methodist DeBakey Heart &, Vascular Center, The Methodist Hospital, 6550 Fannin Street, Houston, 77030, Texas, USA

    Alan B. Lumsden

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

El-Sayed, H.F. (2012). Deep Venous Thrombosis. In: Hoballah, J., Lumsden, A. (eds) Vascular Surgery. New Techniques in Surgery Series, vol 6. Springer, London. https://doi.org/10.1007/978-1-4471-2912-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2912-7_18

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2911-0

  • Online ISBN: 978-1-4471-2912-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation